Flagship Pioneering Innovations V, Inc.

Simon Delagrave

Avak Kahvejian

Erica Gabrielle Weinstein

Kevin James Lebo

Fernando Martin Diaz

Dhananjay Maniklal Nawandar

Ryan D Tedstone

Nathan Lawrence Yozwiak

Jared David Pitts

This invention relates generally to viral vectors and viral particles based on Anelloviruses, which can be used to deliver an agent (e.g., an exogenous effector or an endogenous effector, e.g., a therapeutic effector) to a cell (e.g., a cell in a subject to be treated therapeutically). Described herein are anellosomes, anellovectors, and compositions and uses thereof.

Anellovirus compositions and methods of use

This invention relates generally to viral vectors and viral particles based on, which can be used to deliver an agent (e.g., an exogenous effector or an endogenous effector, e.g., a therapeutic effector) to a cell (e.g., a cell in a subject to be treated therapeutically). Described herein are anellosomes, anellovectors, and compositions and uses thereof.

Growing community of inventors

Sudbury, MA, United States of America

Simon Delagrave